Fingerprint Dive into the research topics of 'Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II
Research output: Contribution to journal › Article › peer-review
61
Scopus
citations